IMA is loading

Main Financial Data 1999

Main Data: 31/12 Year 1999
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 240.18
– gross margin 112.32
– total operating cost 79.60
– net operating profit 31.54
– financial expenses, net 4.06
– net income before taxes 15.58

 

Consolidated balance sheet Millions/Euro
– operating capital 88.79
– fixed assets, net 49.47
– reserves and MLT non financial payables – 18.20
– net financial position – 41.69
– stockholders’ equity 78.37

 

Other information Millions/Euro
– depreciation 9.08
– R & D expenses 12.80

 

  Euro
Dividend per share 0.20

 

  No.
Employees 1,755

 

  Lire
Shares outstanding 36,100,000,000

 

Main Data: 30/06 Year 1999
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 104.18
– gross margin 49.50
– total operating cost 38.83
– net operating profit 11.13
– financial expenses, net 2.02
– net income before taxes 9.15

 

Consolidated balance sheet Millions/Euro
– operating capital 82.82
– fixed assets, net 48.08
– reserves and MLT non financial payables – 20.07
– net financial position – 39.44
– stockholders’ equity 71.38

 

Other information Millions/Euro
– depreciation 4.45
– R & D expenses 6.31

 

  No.
Employees 1,727

 

  Lire
Shares outstanding 36,100,000,000

 

Net Sales by Country: Year 1999
  Millions/Euro  
E.U. (excluding Italy) 91.21 38.39%
Other European countries 15.37 6.40%
North America 48.78 20.31%
Asia & Middle East 22.75 9.47%
Other countries 38.69 16.11%
Total exports 217.80 90.68%
Italy 22.38 9.32%
Total 240.18 100.00%
Dismissclose

IMA Pharma
@ Achema

Explore the dedicated website and get a free entry pass with IMA